Your browser doesn't support javascript.
loading
Polycystic ovarian syndrome-current pharmacotherapy and clinical implications.
Rashid, Rumaisa; Mir, Suhail Ahmad; Kareem, Ozaifa; Ali, Tabassum; Ara, Rifat; Malik, Anjum; Amin, Fiza; Bader, G N.
  • Rashid R; Department of Pharmaceutical Sciences, University of Kashmir, Hazratbal, Srinagar, 190006, India. Electronic address: rumaisa.scholar@kashmiruniversity.net.
  • Mir SA; Department of Pharmaceutical Sciences, University of Kashmir, Hazratbal, Srinagar, 190006, India. Electronic address: suhailmir.scholar@kashmiruniversity.net.
  • Kareem O; Department of Pharmaceutical Sciences, University of Kashmir, Hazratbal, Srinagar, 190006, India. Electronic address: ozaifa.scholar@kashmiruniversity.net.
  • Ali T; Department of Pharmaceutical Sciences, University of Kashmir, Hazratbal, Srinagar, 190006, India. Electronic address: tabasumali.ku@gmail.com.
  • Ara R; Department of Obstetrics & Gynaecology, Sheri Kashmir Institute of Medical Sciences, Medical College & Hospital, Bemina, Srinagar, 190001, India. Electronic address: rifatara8@gmail.com.
  • Malik A; Department of Obstetrics & Gynaecology, Sheri Kashmir Institute of Medical Sciences, Medical College & Hospital, Bemina, Srinagar, 190001, India. Electronic address: amalik5152@gmail.com.
  • Amin F; Department of Gynaecology and Obstetrics, Lala Ded Hospital, Govt Medical College Srinagar, India. Electronic address: Fizamink@gmail.com.
  • Bader GN; Department of Pharmaceutical Sciences, University of Kashmir, Hazratbal, Srinagar, 190006, India. Electronic address: gnbader@kashmiruniversity.ac.in.
Taiwan J Obstet Gynecol ; 61(1): 40-50, 2022 Jan.
Article en En | MEDLINE | ID: mdl-35181044

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Síndrome del Ovario Poliquístico / Vitamina D / Inhibidores de Hidroximetilglutaril-CoA Reductasas / Terapia por Láser / Letrozol / Hipoglucemiantes Límite: Female / Humans Idioma: En Año: 2022 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Síndrome del Ovario Poliquístico / Vitamina D / Inhibidores de Hidroximetilglutaril-CoA Reductasas / Terapia por Láser / Letrozol / Hipoglucemiantes Límite: Female / Humans Idioma: En Año: 2022 Tipo del documento: Article